ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
78 hedge funds and large institutions have $321M invested in ANACOR PHARMACEUTICALS INC COM in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
107% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 15
95% more capital invested
Capital invested by funds: $165M → $321M (+$157M)
16% more funds holding
Funds holding: 67 → 78 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$6.45M |
| 2 |
PA
Perceptive Advisors
New York
|
+$3.42M |
| 3 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$2.17M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.81M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$1.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
-$3.82M |
| 2 |
PWPCM
Perella Weinberg Partners Capital Management
New York
|
-$2.57M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$2.23M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.92M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$1.88M |
ANAC Hedge Fund Activity: Q3 2013 in Review
78 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2013, worth a combined $321M — up 95% from $165M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ANAC positions and 8 closed out — a net gain of 11 holders — while 31 added to existing stakes and 15 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $6.45M. The largest seller was Columbus Circle Investors, cutting an estimated $3.82M.
- 78 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2013, up from 67 in Q2 2013.
- Funds reported $321M of ANACOR PHARMACEUTICALS INC COM stock for Q3 2013, up 95% quarter-over-quarter.
- 19 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2013 and 8 closed out, a net change of +11 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2013 was Consonance Capital Management, an estimated $6.45M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2013 was Columbus Circle Investors, an estimated $3.82M sold.
Based on aggregated 13F filings for Q3 2013.